MDB Capital Holdings LLC, through its PatentVest division, has released a new PatentVest Pulse report analyzing the rapidly evolving $133 billion global cardiac diagnostics market. The report highlights how the integration of consumer technology, ambulatory monitoring, and traditional medical systems is reshaping cardiac care, with intellectual property ownership poised to determine future market leaders. Traditional device manufacturers such as Philips, GE Healthcare, and Nihon Kohden are facing increasing competition from innovators like HeartBeam, AliveCor, Mayo Clinic, Tempus AI, Eko Health, Anumana, Medical AI Co., and Bodyfriend Co. The report identifies a shift from hospital-based diagnostics to portable, connected systems, noting HeartBeam's advancement as the first to achieve cable-free 12-lead ECG technology. Consumer wearables from Apple, Samsung, Google, and others have popularized heart rate tracking and single-lead ECGs, but these technologies remain limited to rhythm screening and lack full diagnostic capabilities. PatentVest's analysis of 581 patent families across 243 organizations underscores how control over enabling IP will be crucial in shaping the next era of cardiac diagnostics.